Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHIP Trial
2006-005715-10Phase 4Completed
- Sponsor
- Royal Brompton and Harefield hospitals
- Start
- Mar 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of human insulin in hyperglycemia (2 arms), sponsored by Royal Brompton and Harefield hospitals. Primary endpoint: Days alive and free from mechanical ventilation within 30 days after trial entry. Started Mar 2007; status: completed.
02
Drugs
human insulin
03
Conditions
hyperglycemia
Beyond the preview
Go deeper on 2006-005715-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005715-10.